AstraZeneca’s Tagrisso Recommended for Approval in EU for Unresectable EGFR-Mutated NSCLC

Foundation Medicine Receives FDA Approval for FoundationOne®Liquid CDx as a Companion Diagnostic for TEPMETKO® in NSCLC

Exact Sciences Partners with Carlos Ponce to Boost Colorectal Cancer Awareness in the Hispanic Community

Merck Receives Positive CHMP Opinion for KEYTRUDA® in Combination Therapy for First-Line Treatment of Non-Epithelioid Mesothelioma

Australia Launches Genomics Australia to Lead Advances in Genomic Medicine

Sidra Medicine Unveils Masterclasses Ahead of PMFG 2024 Summit

FDA Approves Revuforj® as First Menin Inhibitor for Acute Leukemia with KMT2A Translocation

CHMP Recommends Approval of Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H/dMMR Metastatic Colorectal Cancer

ADDF Invests $1.18M to Standardize p-tau217 Blood Tests for Alzheimer’s Diagnosis

GSK Reports Positive Interim Results for DREAMM-7 Trial of Blenrep in Multiple Myeloma

Molbio Diagnostics Invests $30 Million in OptraSCAN to Revolutionize Digital Pathology

BioNTech Acquires Chinese Oncology Firm Biotheus for $950M

The Care and Protection of Children Trust

CPCT Launches Groundbreaking Initiative to Provide Lifelong Free Treatment for Children with Spinal Muscular Atrophy (SMA) in Karnataka

Early Comprehensive Genomic Profiling Improves Cancer Treatment Outcomes, Study Shows

EMA Reverses Decision, Recommends Limited Approval for Eisai and Biogen’s Alzheimer’s Drug Leqembi

Home
/
insight
/
details

Scope of precision medicine in rare diseases and creation of orphan drugs

NextEdge Admin

06 Sep 2023

4 min 13 sec

Precision medicine holds significant promise in the field of rare diseases and orphan drugs. Rare diseases are often characterized by their low prevalence, and many of them are caused by genetic mutations. This makes them an ideal candidate for precision medicine approaches. Here’s the scope and potential impact of precision medicine in rare diseases and orphan drugs:

Genetic Characterization: Precision medicine focuses on identifying the specific genetic or molecular causes of diseases. In rare diseases, pinpointing the exact genetic mutation responsible for the condition can lead to more accurate diagnoses and tailored treatments. This can potentially improve the quality of life for individuals with rare diseases.
Personalized Therapies: Rare diseases are often heterogeneous, meaning they can vary greatly from one patient to another. Precision medicine allows for the development of personalized therapies based on a patient’s unique genetic profile. This can result in more effective treatments with fewer side effects.
Targeted Drug Development: Precision medicine enables the development of drugs that specifically target the genetic or molecular abnormalities underlying a rare disease. This approach can lead to the creation of orphan drugs, which are medications designed for rare diseases. These drugs may not have a broad market, but they can be life-changing for those who need them.
Rare Disease Diagnosis: Rapid advances in genomics and molecular biology have made it easier to diagnose rare diseases accurately. In some cases, it can take years for individuals with rare diseases to receive a correct diagnosis. Precision medicine can significantly reduce diagnostic delays, improving patient outcomes.
Repurposing Existing Drugs: Precision medicine can identify existing drugs that might be effective for rare diseases with similar molecular mechanisms. This can expedite the development of treatments for rare diseases by leveraging existing pharmaceuticals.
Clinical Trials and Research: Precision medicine can aid in the design of more targeted clinical trials for rare diseases. This can lead to faster and more conclusive results, facilitating the approval of new therapies. Moreover, it can attract more investment in rare disease research.
Patient Registries and Data Sharing: Collaborative efforts and data sharing are essential in the study of rare diseases. Precision medicine can help establish patient registries, collect valuable data, and connect patients and researchers worldwide. This can lead to a better understanding of these conditions and accelerate drug development.

Global Collaboration: Rare diseases often transcend national borders. International collaboration is crucial to advance precision medicine in this field. Sharing research, data, and resources can accelerate progress.

Related Tags

precision medicine

orphan drugs

What is CAR-T cell therapy?

What is Pharmacogenomics (PGx) and pharmacogenetics?

Top Reviews

No reviews yet